Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens

Rationale: Azithromycin has been shown to improve lung function and reduce the number of pulmonary exacerbations in patients with cystic fibrosis. Concerns remain, however, regarding the potential emergence of treatment-related respiratory pathogens. Objectives: To determine whether chronic azithrom...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ann Am Thorac Soc
Hoofdauteurs: Cogen, Jonathan D., Onchiri, Frankline, Emerson, Julia, Gibson, Ronald L., Hoffman, Lucas R., Nichols, David P., Rosenfeld, Margaret
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Thoracic Society 2018
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850787/
https://ncbi.nlm.nih.gov/pubmed/29474110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201801-012OC
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items